BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 12037567)

  • 1. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    Li S; Strittmatter SM
    J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
    Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
    Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.
    Fournier AE; Gould GC; Liu BP; Strittmatter SM
    J Neurosci; 2002 Oct; 22(20):8876-83. PubMed ID: 12388594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
    Liu BP; Fournier A; GrandPré T; Strittmatter SM
    Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
    J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
    Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
    Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
    Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?
    Teng FY; Tang BL
    J Neurochem; 2005 Aug; 94(4):865-74. PubMed ID: 16092935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroscience. It takes more than two to Nogo.
    Woolf CJ; Bloechlinger S
    Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
    Domeniconi M; Cao Z; Spencer T; Sivasankaran R; Wang K; Nikulina E; Kimura N; Cai H; Deng K; Gao Y; He Z; Filbin M
    Neuron; 2002 Jul; 35(2):283-90. PubMed ID: 12160746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats.
    Atalay B; Bavbek M; Cekinmez M; Ozen O; Nacar A; Karabay G; Gulsen S
    Spinal Cord; 2007 Dec; 45(12):780-6. PubMed ID: 17724451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.
    Steward O; Sharp K; Yee KM; Hofstadter M
    Exp Neurol; 2008 Feb; 209(2):446-68. PubMed ID: 18234196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
    Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of RNAi NgR and NEP1-40 in Acting on Axonal Regeneration After Spinal Cord Injury in Rat Models.
    Xu J; He J; He H; Peng R; Xi J
    Mol Neurobiol; 2017 Dec; 54(10):8321-8331. PubMed ID: 27921243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.